Akrolyth

Akrolyth Advisory provides expert corporate development services for Life Sciences, supporting biopharma and medtech companies, investors, translational groups, and startups on evaluating, buying/selling/licensing, developing, and commercializing new therapies and products. Key areas of expertise: - M&A/licensing analytics and deal support (buy- and sell-side) - Modeling, forecasting, and valuation (recognized SMEs) - Commercial assessments and due diligence - Product/portfolio development and strategic planning We specialize in providing customized solutions to non-traditional business challenges, combining expert analytical acumen with in-depth and wide-ranging market experience. Akrolyth has a broad range of experience across multiple therapeutic areas, with particular expertise in rare/orphan diseases and specialty therapies. We have worked extensively on the US and EU markets, as well as Latin America and Asia.